Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    First ever CRISPR gene therapy approval: What happens next?

    First ever CRISPR gene therapy approval: What happens next?

    FromBioSpace

    Start listeningView podcast show

    First ever CRISPR gene therapy approval: What happens next?

    FromBioSpace

    ratings:
    Length:
    13 minutes
    Released:
    Nov 21, 2023
    Format:
    Podcast episode

    Description

    Last Thursday, the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) approved CRISPR/Cas9 gene-edited therapy exagamglogene autotemcel (exa-cel). Will the FDA follow suit? What can patients expect the price tag to be?

    Plus, a good handful of approvals for AstraZeneca, Pfizer and Astellas' Xtandi, and Keytruda.

    Join BioSpace's Lori Ellis, Greg Slabodkin and Heather McKenzie as they discuss the news this week.
    Released:
    Nov 21, 2023
    Format:
    Podcast episode

    Titles in the series (46)

    Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.